|Primary analysis complete
|Study Start Date:
|Study Made Public:
A Phase I trial to evaluate the safety and immunogenicity of the HIV-1 pGA2/JS2 plasmid DNA vaccine given intramuscularly (IM) in HIV-1 uninfected adults
HVTN 045 is a Phase I clinical trial to evaluate the safety and immunogenicity of HIV-1 pGA2/JS2 plasmid DNA.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.